2017 Annual General Meeting of Shareholders
(28th February 2017)
February 8, 2017
Dear All,
The proxy advisor, Institutional Shareholder Services (ISS), issued their report on Novartis in advance of the Novartis
Annual General Meeting.
For your information, please find attached to this email (also on the following link
https://www.novartis.com/investors/shareholder-information/annual-general-meeting), the response to the ISS report
from Mr. Enrico Vanni, Chairman of the Compensation Committee, Novartis.
If you have any questions or require clarification please do not hesitate to contact the Investor Relations team.
Thank you and kind regards
Novartis International AG
Investor Relations
Basel Office | |
General Phone | +41 61 324 79 44 |
Samir Shah | +41 61 324 79 44 |
Pierre-Michel Bringer | +41 61 324 10 65 |
Thomas Hungerbuehler | +41 61 324 84 25 |
Isabella Zinck | +41 61 324 71 88 |
North America Office | |
Richard Pulik | +1 212 830 24 48 |
Sloan Pavsner | +1 212 830 24 17 |
Email: investor.relations@novartis.com www.novartis.com |